Nyxoah (NYXH) announced that the FDA has approved the Genio system for a subset of patients with moderate to severe OSA with an Apnea-Hypopnea Index of greater than or equal to 15 and less than or equal to 65.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NYXH: